Products for Research Use Only

Trifluoperazine-d8

CAT: 0804-HY-B0532S-01Size: 500 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0532S-01Size:500 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Trifluoperazine-d8 is a deuterium labeled Trifluoperazine. Trifluoperazine is an antipsychotic phenothiazine agent and a selective α1-adrenergic receptor antagonist. Trifluoperazine is also a potent dopamine D2 receptor inhibitor [1][2].
UNSPSC
12352005
Target
Adrenergic Receptor; Autophagy; Dopamine Receptor; Influenza Virus; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection; Autophagy; GPCR/G Protein; Neuronal Signaling; Others
Applications
COVID-19-anti-virus
Field of Research
Cancer; Neurological Disease
Solubility
10 mM in DMSO
Smiles
FC(C(C=C1N2CCCN3C([2H])([2H])C([2H])([2H])N(C)C([2H])([2H])C3([2H])[2H])=CC=C1SC4=C2C=CC=C4)(F)F
Molecular Formula
C21H16D8F3N3S
Molecular Weight
415.54
References & Citations
[1]Huerta-Bahena J, et al. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects. Mol Pharmacol. 1983 Jan;23 (1) :67-70.|[2]Marques LO, et al. Trifluoperazine for schizophrenia. Cochrane Database Syst Rev. 2004; (1) :CD003545.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported